Table 1.
Clinical and tumor biological characteristics for 786 neuroblastoma cases.
| Characteristic | Neuroblastoma sequencing cohort n (%) | |
|---|---|---|
|
| ||
| Age | ||
| < 18 months | 242 | 30.8% |
| ≥ 18 months | 544 | 69.2% |
|
| ||
| Sex | ||
| Female | 339 | 43.1% |
| Male | 447 | 56.9% |
|
| ||
| COG Risk | ||
| Low | 103 | 13.2% |
| Intermediate | 119 | 15.1% |
| High | 564 | 71.8% |
|
| ||
| INSS Stage | ||
| Stage 1 | 38 | 4.8% |
| Stage 2 | 60 | 7.7% |
| Stage 3 | 93 | 11.8% |
| Stage 4 | 546 | 69.5% |
| Stage 4S | 49 | 6.2% |
|
| ||
| MYCN Status | ||
| Not amplified | 552 | 71.1% |
| Amplified | 224 | 28.9% |
| Not available | 10 | |
|
| ||
| Histology | ||
| Favorable | 211 | 28.8% |
| Unfavorable | 522 | 71.2% |
| Not available | 53 | |
|
| ||
| Ploidy | ||
| Hyperdiploid | 473 | 61.7% |
| Diploid | 293 | 38.3% |
| Not available | 20 | |
COG: Children’s Oncology Group
INSS: International Neuroblastoma Staging System